Oncology Clinical Trials Finance Analyst

University of California - Irvine; California; On-site; USD 90,000 - 120,000; Full time

Job summary

University of California, Irvine seeks a Clinical Research Finance Analyst within the Department of Urology to manage the financials for a portfolio of cancer trials. You will partner with investigators, trial teams, and finance offices to ensure accurate post-award reporting and responsible stewardship of sponsored funds.

You will monitor budgets, invoicing, oversee accounts receivable/payable for ~40-60 trial accounts, and provide forecasting and financial insights to support trial delivery

Qualifications

• Experience with clinical trial agreements and billing principles.
• Knowledge of finance policies and systems.
• Ability to organize information for financial analysis.
• Strong written and verbal communication skills.
• Proficiency with spreadsheet and database software for analyses.
• Ability to multi-task in a high-volume environment and adapt to priorities.

Responsibilities

• Oversee financial management of complex urology oncology trials.
• Monitor budgets, expenditures, invoicing, and financial performance.
• Ensure sponsor regulations and institutional policies are followed.
• Provide strategic financial analysis, forecasting, and problem-solving.

Skills

Clinical trial agreements

Finance policies

Financial analysis

Budgeting & forecasting

Communication skills

Interpersonal skills

Multi-tasking

Internal controls

Team collaboration

Education

Bachelor's degree in related area

Tools

Oncore CTMS

KFS

DSS

Data Warehouse

PI Report

Job description

University of California, Irvine seeks a Clinical Research Finance Analyst within the Department of Urology to manage the financials for a portfolio of cancer trials. You will partner with investigators, trial teams, and finance offices to ensure accurate post-award reporting and responsible stewardship of sponsored funds.

You will monitor budgets, invoicing, oversee accounts receivable/payable for ~40-60 trial accounts, and provide forecasting and financial insights to support trial delivery